Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA/CMS Data Sharing Encouraged In Senate Appropriations Report

Executive Summary

Senate appropriators are pushing for more interaction between FDA and the Centers for Medicare and Medicaid Services during medical product reviews.
Advertisement

Related Content

FDA's Medical Countermeasure Program Among Senate Funding Priorities
FDA's Medical Countermeasure Program Among Senate Funding Priorities
CER Has Been A Part Of CMS Coverage Decisions In Recent Years – Avalere
FDA And CMS Agree To Share Data Routinely In Step Toward Parallel Reviews

Topics

Advertisement
UsernamePublicRestriction

Register

PS053756

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel